EGFR blockade confers sensitivity to pan-RAS inhibitors in KRAS-mutated cancers.

Saved in:
Bibliographic Details
Title: EGFR blockade confers sensitivity to pan-RAS inhibitors in KRAS-mutated cancers.
Authors: Han, Junling1,2 (AUTHOR), Yu, Bo2,3 (AUTHOR), Jing, Jianan2,3,4 (AUTHOR), He, Xiaoyu2,3 (AUTHOR), Hua, Yunfen1 (AUTHOR) huayf@zjut.edu.cn, Xu, Guotai2,3 (AUTHOR) xuguotai@nibs.ac.cn
Source: Cellular Oncology (2211-3428). Oct2025, Vol. 48 Issue 5, p1317-1335. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:22113428
DOI:10.1007/s13402-025-01075-4